Impax Small Cap Fund Investor Class PXSCX

Medalist Rating as of | See Impax Investment Hub
  • NAV / 1-Day Return 21.33  /  +0.61 %
  • Total Assets 891.1M
  • Adj. Expense Ratio
    1.160%
  • Expense Ratio 1.160%
  • Distribution Fee Level Average
  • Share Class Type No Load
  • Category Small Blend
  • Investment Style Small Blend
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 0.00
  • Turnover 36%

USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 12:11 AM GMT+0

Morningstar’s Analysis PXSCX

Will PXSCX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Impax Small Cap Investor holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings PXSCX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 31.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Victory Capital Holdings Inc Class A

4.96 47M
Financial Services

JPMorgan US Treasury Plus MMkt IM

4.77 45M
Cash and Equivalents

Crinetics Pharmaceuticals Inc

3.88 37M
Healthcare

Pinnacle Financial Partners Inc

3.47 33M
Financial Services

Agree Realty Corp

3.04 29M
Real Estate

Acadian Asset Management Inc

2.97 28M
Financial Services

Eastern Bankshares Inc Ordinary Shares

2.94 28M
Financial Services

SI-BONE Inc

2.85 27M
Healthcare

Neurocrine Biosciences Inc

2.59 25M
Healthcare

Ligand Pharmaceuticals Inc

2.24 21M
Healthcare

Sponsor Center